ALOX12B
protein-codingarachidonate 12-lipoxygenase, 12R type, the group of Arachidonate lipoxygenases
Gene summary
This gene encodes an enzyme involved in the conversion of arachidonic acid to 12R-hydroxyeicosatetraenoic acid. Mutations in this gene are associated with nonbullous congenital ichthyosiform erythroderma. [provided by RefSeq, Sep 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~15.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0017267
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019306
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009439
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0019306
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009439
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0017778
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009439
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009439
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Dermatologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ALOX12B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001139.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 34 | 3 | 45 | ||
| missense | 44 | 39 | 145 | 9 | 1 | 238 |
| nonsense | 14 | 6 | 1 | 21 | ||
| start loss | 1 | 1 | ||||
| frameshift | 27 | 9 | 36 | |||
| splice donor/acceptor (+/-2bp) | 9 | 7 | 1 | 17 | ||
| Total | 94 | 62 | 155 | 43 | 4 | 358 |
Highest pathogenic variant AF is 0.0001226819
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001130.1 | 15 | MANE Select | |
| Ensembl | ENSP00000497784.1 | 15 | MANE Select | |
| Ensembl | ENSP00000496845.1 | 8 | Standard | |
| Ensembl | ENSP00000815156.1 | 15 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Serotonergic synapse - Homo sapiens (human)
- Arachidonic acid metabolism - Homo sapiens (human)
- Etodolac Action Pathway
- Ketoprofen Action Pathway
- Ibuprofen Action Pathway
Biological Process
- protein lipidation
- sphingolipid metabolic process
- positive regulation of gene expression
- arachidonic acid metabolic process
- lipoxygenase pathway
Molecular Function
- arachidonate 12-lipoxygenase activity
- iron ion binding
- protein binding
- oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
- linoleate 9S-lipoxygenase activity
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000319144
- Coding exons
- 15
- Length
- 15068
- Individuals with no LoFs
- 125692
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 56
- Defined
- 125748
- p
- 0.000223
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.40 | 326 | 406 | 0.804 | 0.0000238 | 4553 |
| Missense (PolyPhen) | 103 | 157 | 0.65604 | 1751 | ||
| Synonymous | 0.599 | 158 | 168 | 0.941 | 0.0000101 | 1395 |
| Loss of Function | 3.63 | 12 | 35.2 | 0.340 | 0.00000169 | 400 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00027 | 0.00026 | rare |
| South Asian | 0.00059 | 0.00056 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids generating a spectrum of bioactive lipid mediators. Mainly converts arachidonic acid to (12R)- hydroperoxyeicosatetraenoic acid/(12R)-HPETE and minor stereoisomers. In the skin, acts upstream of ALOXE3 on the lineolate moiety of esterified omega-hydroxyacyl-sphingosine (EOS) ceramides to produce an epoxy-ketone derivative, a crucial step in the conjugation of omega-hydroxyceramide to membrane proteins. Therefore plays a crucial role in the synthesis of corneocytes lipid envelope and the establishment of the skin barrier to water loss. May also play a role in the regulation of the expression of airway mucins. {ECO:0000269|PubMed:21558561, ECO:0000269|PubMed:22441738, ECO:0000269|PubMed:9618483}.;
Intolerance Scores
- LoFtool
- 0.257
- RVIS EVS
- -0.62
- RVIS percentile EVS
- 17.4
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.389
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |